Health and Fitness Health and Fitness
Tue, November 15, 2011
[ Tue, Nov 15th 2011 ] - Market Wire
CytoSorbents Corporation Reports Third Quarter 2011 Financial Results and Corporate Update
[ Tue, Nov 15th 2011 ] - Market Wire
PharmaGap Announces Start of Definitive Animal Ef .. cacy Study Required to Proceed to Clinical Trials
[ Tue, Nov 15th 2011 ] - Market Wire
International Stem Cell Corporation Announces Third Quarter 2011 Financial Results
[ Tue, Nov 15th 2011 ] - Market Wire
Alnylam to Present Phase I Clinical Data at VIIIt .. Symposium on Familial Amyloidotic Polyneuropathy
[ Tue, Nov 15th 2011 ] - Market Wire
Palatin Technologies, Inc. Reports First Quarter .. #59; Teleconference and Webcast to be held on Nov
[ Tue, Nov 15th 2011 ] - Market Wire
FONAR Announces 1st Quarter Fiscal 2012 Financial .. ults as Net Income Increases 360% to $1.8 Million
[ Tue, Nov 15th 2011 ] - Market Wire
Geron Presents Final Phase 1 Clinical Data on GRN1005 at AACR-NCI-EORTC
[ Tue, Nov 15th 2011 ] - Market Wire
Implant Sciences' QS-H150 Explosives Trace Detector Deployed at Third Airport in India
[ Tue, Nov 15th 2011 ] - Market Wire
Given Imaging Initiates Pivotal Trial for PillCam(R) COLON 2 in Japan
[ Tue, Nov 15th 2011 ] - Market Wire
Extended-Time Accessories to Optimize Customers' Return on Investment
[ Tue, Nov 15th 2011 ] - Market Wire
Titan Pharmaceuticals Enters Into $15 Million Royalty Sale Agreement With Deerfield Management
[ Tue, Nov 15th 2011 ] - Market Wire
Titan Pharmaceuticals Announces Third Quarter 2011 Financial Results
[ Tue, Nov 15th 2011 ] - Market Wire
Cigna Appoints Phil Austin to Lead Individual Cigna Global Health Options (CGHO) Business
[ Tue, Nov 15th 2011 ] - Market Wire
Greystone Logistics Purchase Orders Fill Capacity
[ Tue, Nov 15th 2011 ] - Market Wire
IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
[ Tue, Nov 15th 2011 ] - Market Wire
Covidien presenta i risultati del quarto trimestre e dell'anno fiscale 2011
[ Tue, Nov 15th 2011 ] - Market Wire
China Medical Technologies Announces Payment on M .. ts 3.5% Convertible Senior Subordinated Notes due
Mon, November 14, 2011
[ Mon, Nov 14th 2011 ] - Market Wire
Columbia Laboratories Will Present November 15th at Lazard Capital Markets Healthcare Conference
[ Mon, Nov 14th 2011 ] - Market Wire
Robbins Umeda LLP Announces an Investigation of Abbott Laboratories
[ Mon, Nov 14th 2011 ] - Market Wire
Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering
[ Mon, Nov 14th 2011 ] - Market Wire
Permian Investment Partners Opposes Sun Pharmaceu .. aro Pharmaceutical Industries at $24.50 Per Share
[ Mon, Nov 14th 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against Human Genome Sciences, Inc.
[ Mon, Nov 14th 2011 ] - Market Wire
ProMetic Reports its Third Quarter 2011 Highlights, Financial Results and Subsequent Events
[ Mon, Nov 14th 2011 ] - Market Wire
ADVISE Study Results Demonstrate the Instant Wave .. -Free Measure of Stenosis Severity, is Comparable
[ Mon, Nov 14th 2011 ] - Market Wire
Nephros Reports Third Quarter 2011 Financial Results
[ Mon, Nov 14th 2011 ] - Market Wire
Pharmasset Reports Fiscal Year End 2011 Financial Results
[ Mon, Nov 14th 2011 ] - Market Wire
Warnex Reports Third Quarter 2011 Results
[ Mon, Nov 14th 2011 ] - Market Wire
Kindred Healthcare, Inc. Announces Results of the .. xchange Offer for Its 8.25% Senior Notes Due 2019
[ Mon, Nov 14th 2011 ] - Market Wire
The Medicines Company's MDCO-216 (ApoA-I Milano C .. to Clear Cholesterol From Cells in Preclinical M
[ Mon, Nov 14th 2011 ] - Market Wire
Gilead Sciences to Present at the Lazard Capital .. ual Healthcare Conference on Tuesday, November 15

Gilead Sciences to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15


Published on 2011-11-14 13:45:20 - Market Wire
  Print publication without navigation


FOSTER CITY, Calif.--([ ])--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Lazard Capital Markets 8th Annual Healthcare Conference in New York.

John C. Martin, PhD, Gileadas Chairman and Chief Executive Officer, will provide an overview of the company on Tuesday, November 15 at 1:00 p.m. Eastern Time.

To access the live webcast or a replay via the Internet, log on to [ www.gilead.com ]. Please connect to the companyas website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companyas mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit [ www.gilead.com ] or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contributing Sources